{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:45:40Z","timestamp":1791027940807,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11313-5","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:29:19Z","timestamp":1764656959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The influence of blood levels of circRNAs and microRNAs on the development of ulcerative colitis"],"prefix":"10.1007","volume":"53","author":[{"given":"Mai A. H.","family":"Abouelenin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-0256","authenticated-orcid":false,"given":"Safaa I.","family":"Tayel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa S.","family":"Elabd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa M.","family":"Seddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"El-Masry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Elbahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda I.","family":"Abd-Elhafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed G.","family":"Elhelbawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada E.","family":"Elgarawany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba F.","family":"Khader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"13","key":"11313_CR1","doi-asserted-by":"publisher","first-page":"7062","DOI":"10.3390\/ijms25137062","volume":"25","author":"E Diez-Martin","year":"2024","unstructured":"Diez-Martin E, Hernandez-Suarez L, Mu\u00f1oz-Villafranca C, Martin-Souto L, Astigarraga E, Ramirez-Garcia A, Barreda-G\u00f3mez G (2024) Inflammatory bowel disease: A comprehensive analysis of molecular Bases, predictive Biomarkers, diagnostic Methods, and therapeutic options. Int J Mol Sci 25(13):7062","journal-title":"Int J Mol Sci"},{"key":"11313_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/medicina58050567","volume":"58","author":"AE M\u2019Koma","year":"2022","unstructured":"M\u2019Koma AE (2022) Inflammatory bowel disease: clinical diagnosis and surgical Treatment-Overview. Medicina 58:567","journal-title":"Medicina"},{"key":"11313_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HSP De Souza","year":"2016","unstructured":"De Souza HSP, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the Art. Nat Rev Gastroenterol Hepatol 13:13\u201327","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"11313_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.21608\/aeji.2021.90989.1167","volume":"11","author":"A Ellehleh","year":"2021","unstructured":"Ellehleh A, Elabd N, Azmy R, Tselepis C, Shaheen W (2021) Gut microbiota characteristics in ulcerative colitis and other Gastrointestinal Diseases. Afro-Egyptian J Infect Endemic Dis 11(4):320\u2013330. https:\/\/doi.org\/10.21608\/aeji.2021.90989.1167","journal-title":"Afro-Egyptian J Infect Endemic Dis"},{"issue":"241","key":"11313_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10238-024-01476-z","volume":"11","author":"YN Ramadan","year":"2024","unstructured":"Ramadan YN, Kamel AM, Medhat MA, Hetta HF (2024) MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease. Clin Exp Med 11(241):217","journal-title":"Clin Exp Med"},{"issue":"3","key":"11313_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1055\/s-0037-1602237","volume":"31","author":"RW Stidham","year":"2018","unstructured":"Stidham RW, Higgins PDR (2018) Colorectal cancer in inflammatory bowel disease. Clin Colon Rectal Surg 31(3):168\u2013178","journal-title":"Clin Colon Rectal Surg"},{"key":"11313_CR7","doi-asserted-by":"publisher","first-page":"G256","DOI":"10.1152\/ajpgi.00268.2017","volume":"314","author":"A Soroosh","year":"2018","unstructured":"Soroosh A, Koutsioumpa M, Pothoulakis C, Iliopoulos D (2018) Functional role and therapeutic targeting of MicroRNAs in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 314:G256\u2013G262","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11313_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of MicroRNA Biogenesis, mechanisms of Actions, and circulation. Front Endocrinol (Lausanne) 9:402","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11313_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.tips.2019.09.007","volume":"40","author":"Q Lu","year":"2019","unstructured":"Lu Q, Wu R, Zhao M, Garcia-Gomez A, Ballestar E (2019) MiRNAs as therapeutic targets in inflammatory disease. Trends Pharmacol Sci 40:853\u2013865","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"11313_CR10","doi-asserted-by":"publisher","first-page":"C367","DOI":"10.1152\/ajpcell.00051.2022","volume":"323","author":"LT Dalgaard","year":"2022","unstructured":"Dalgaard LT, S\u00f8rensen AE, Hardikar AA, Joglekar MV (2022) The microRNA-29 family: role in metabolism and metabolic disease. Am J Physiol Cell Physiol 323(2):C367\u2013C377","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"11313_CR11","first-page":"8542","volume":"7","author":"B Lv","year":"2014","unstructured":"Lv B, Liu Z, Wang S, Liu F, Yang X, Hou J, Hou Z, Chen B (2014) MiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1. Int J Clin Exp Pathol 7(12):8542\u20138552","journal-title":"Int J Clin Exp Pathol"},{"key":"11313_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","volume":"87","author":"SM Hammond","year":"2015","unstructured":"Hammond SM (2015) An overview of MicroRNAs. Adv Drug Deliv Rev 87:3\u201314","journal-title":"Adv Drug Deliv Rev"},{"key":"11313_CR13","doi-asserted-by":"crossref","unstructured":"Mao L, Liu S, Hu L, Jia L, Wang H, Guo M, Chen C, Liu Y, Xu L (2018) MiR-30 family: A promising regulator in development and disease. Biomed Res Int ; 29;2018:9623412","DOI":"10.1155\/2018\/9623412"},{"issue":"2","key":"11313_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1053\/j.gastro.2013.10.021","volume":"146","author":"HT Nguyen","year":"2014","unstructured":"Nguyen HT, Dalmasso G, M\u00fcller S, Carri\u00e8re J, Seibold F, Darfeuille-Michaud A (2014) Crohn\u2019s disease-associated adherent invasive Escherichia coli modulate levels of MicroRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 146(2):508\u2013519","journal-title":"Gastroenterology"},{"issue":"12","key":"11313_CR15","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/eji.201747132","volume":"47","author":"M Friedrich","year":"2017","unstructured":"Friedrich M, Pracht K, Mashreghi MF, J\u00e4ck HM, Radbruch A, Seliger B (2017) The role of the miR-148\/-152 family in physiology and disease. Eur J Immunol 47(12):2026\u20132038. https:\/\/doi.org\/10.1002\/eji.201747132","journal-title":"Eur J Immunol"},{"key":"11313_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/or.2016.5257","volume":"37","author":"H Cao","year":"2017","unstructured":"Cao H, Liu Z, Wang R, Zhang X, Yi W, Nie G, Yu Y et al (2017) miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2. Oncol Rep 37:147\u2013154","journal-title":"Oncol Rep"},{"key":"11313_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A, Stottmeister C, Gla\u017ear P, Jens M, Pino N, Giusti S et al (2015) Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell 58:870\u2013885","journal-title":"Mol Cell"},{"key":"11313_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41419-020-2657-z","volume":"11","author":"L Lin","year":"2020","unstructured":"Lin L, Zhou G, Chen P, Wang Y, Han J, Chen M, He Y, Zhang S (2020) Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease? Cell Death Dis 11:456","journal-title":"Cell Death Dis"},{"issue":"1","key":"11313_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ygeno.2021.11.038","volume":"114","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen L, Liu T, Su X, Peng L, Chen J, Tan F, Xing P, Wang Z, Di J, Jiang B, Qu H (2022) Genome-wide circular RNA (circRNA) and mRNA profiling identify a circMET-miR-410-3p regulatory motif for cell growth in colorectal cancer. Genomics 114(1):351\u2013360","journal-title":"Genomics"},{"issue":"12","key":"11313_CR20","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","volume":"14","author":"JD Lewis","year":"2008","unstructured":"Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH (2008) Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 14(12):1660\u20131666","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"11313_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V et al (2022) ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohn\u2019s Colitis 16(1):2\u201317","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"11313_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/ijmm.2024.5474","volume":"55","author":"W Qiu","year":"2025","unstructured":"Qiu W, Akanyibah FA, Xia Y, Ocansey DKW, Mao F, Liang Y (2025) Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review). Int J Mol Med 55(2):33. https:\/\/doi.org\/10.3892\/ijmm.2024.5474","journal-title":"Int J Mol Med"},{"key":"11313_CR23","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.7150\/ijbs.59904","volume":"17","author":"H Jung","year":"2021","unstructured":"Jung H, Kim JS, Lee KH, Tizaoui K, Terrazzino S, Cargnin S, Smith L, Koyanagi A, Jacob L, Li H, Hong SH, Yon DK, Lee SW, Kim MS, Wasuwanich P, Karnsakul W, Shin JI, Kronbichler A (2021) Roles of MicroRNAs in inflammatory bowel disease. Int J Biol Sci 17:2112\u20132123","journal-title":"Int J Biol Sci"},{"key":"11313_CR24","doi-asserted-by":"publisher","first-page":"101079","DOI":"10.1016\/j.bbrep.2021.101079","volume":"27","author":"SE Soliman","year":"2021","unstructured":"Soliman SE, Elabd NS, El-Kousy SM, Awad MF (2021) Down regulation of miR-30a-5p and miR-182-5p in gastric cancer: clinical impact and survival analysis. Biochem Biophys Rep 27:101079. https:\/\/doi.org\/10.1016\/j.bbrep.2021.101079PMID: 34355069; PMCID: PMC8321916","journal-title":"Biochem Biophys Rep"},{"key":"11313_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.abb.2018.04.009","volume":"647","author":"SI Tayel","year":"2018","unstructured":"Tayel SI, Fouda EAM, Gohar SF, Elshayeb EI, El-Sayed EH, El-Kousy SM (2018) Potential role of MicroRNA 200c gene expression in assessment of colorectal cancer. Arch Biochem Biophys 647:41\u201346. https:\/\/doi.org\/10.1016\/j.abb.2018.04.009","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"11313_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1566524019666191019103918","volume":"20","author":"SI Tayel","year":"2020","unstructured":"Tayel SI, Saleh AA, El-Hefnawy SM, Elzorkany KM, Elgarawany GE, Noreldin RI (2020) Simultaneous assessment of MicroRNAs 126 and 192 in diabetic nephropathy patients and the relation of these MicroRNAs with urinary albumin. Curr Mol Med 20(5):361\u2013371. https:\/\/doi.org\/10.2174\/1566524019666191019103918","journal-title":"Curr Mol Med"},{"issue":"2","key":"11313_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/15321819.2024.2447726","volume":"46","author":"AA Saleh","year":"2025","unstructured":"Saleh AA, Tayel SI, Shehata WA, El-Masry EA, Abd-Elhafiz HI, Elhelbawy MG, El-Naidany SS (2025) Estimate of circrnas and MicroRNAs synergies on clinical advance of psoriasis. J Immunoass Immunochem 46(2):147\u2013168. https:\/\/doi.org\/10.1080\/15321819.2024.2447726","journal-title":"J Immunoass Immunochem"},{"key":"11313_CR28","doi-asserted-by":"publisher","unstructured":"Elabd, N. S., Tayel, S. I., Elhamouly, M. S., Hassanein, S. A., Kamaleldeen, S. M.,Ahmed, F. E., \u2026 Sief, A. S. Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals.Hepatic Medicine: Evidence and Research.2021;13,9\u201323. https:\/\/doi.org\/10.2147\/HMER.S292251","DOI":"10.2147\/HMER.S292251"},{"key":"11313_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.immuni.2011.07.009","volume":"35","author":"DF Steiner","year":"2011","unstructured":"Steiner DF et al (2011) MicroRNA-29 regulates T-box transcription factors and interferon-\u03b3 production in helper T cells. Immunity 35:169\u2013181","journal-title":"Immunity"},{"key":"11313_CR30","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2147\/JIR.S302832","volume":"1814","author":"J Guo","year":"2021","unstructured":"Guo J, Zhang R, Zhao Y, Wang J (2021) MiRNA-29c-3p promotes intestinal inflammation via targeting leukemia inhibitory factor in ulcerative colitis. J Inflamm Res 1814:2031\u20132043. https:\/\/doi.org\/10.2147\/JIR.S302832","journal-title":"J Inflamm Res"},{"key":"11313_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.7150\/ijbs.5425","volume":"9","author":"XY Liu","year":"2013","unstructured":"Liu XY, Tang QS, Chen HC, Jiang XL, Fang H (2013) Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity. Int J Biol Sci 9:564\u2013577. https:\/\/doi.org\/10.7150\/ijbs.5425","journal-title":"Int J Biol Sci"},{"key":"11313_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2164-14-139","volume":"14","author":"M Ouzounova","year":"2013","unstructured":"Ouzounova M, Vuong T, Ancey PB, Ferrand M, Durand G, Le-Calvez KF, Croce C, Matar C, Herceg Z, Hernandez-Vargas H (2013) MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics 14:139. https:\/\/doi.org\/10.1186\/1471-2164-14-139","journal-title":"BMC Genomics"},{"issue":"1","key":"11313_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12885-017-3291-8","volume":"17","author":"M Xie","year":"2017","unstructured":"Xie M, Qin H, Luo Q, Huang Q, He X, Yang Z, Lan P, Lian L (2017) MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73. BMC Cancer 17(1):305. https:\/\/doi.org\/10.1186\/s12885-017-3291-8","journal-title":"BMC Cancer"},{"issue":"12","key":"11313_CR34","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1038\/cdd.2017.151","volume":"24","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Gu L, Li Y, Lin X, Shen H, Cui K, Chen L, Zhou F, Zhao Q, Zhang J, Zhong B, Prochownik E, Li Y (2017) miR-148a inhibits colitis and colitis-associated tumorigenesis in mice. Cell Death Differ 24(12):2199\u20132209. https:\/\/doi.org\/10.1038\/cdd.2017.151","journal-title":"Cell Death Differ"},{"issue":"16","key":"11313_CR35","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.18632\/aging.204243","volume":"14","author":"HL Tsai","year":"2022","unstructured":"Tsai HL, Tsai YC, Chen YC, Huang CW, Chen PJ, Li CC, Su WC, Chang TK, Yeh YS, Yin TC, Wang JY (2022) MicroRNA-148a induces apoptosis and prevents angiogenesis with bevacizumab in colon cancer through direct Inhibition of ROCK1\/c-Met via HIF-1\u03b1 under hypoxia. Aging 14(16):6668\u20136688. https:\/\/doi.org\/10.18632\/aging.204243","journal-title":"Aging"},{"issue":"1","key":"11313_CR36","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3892\/ol.2018.9710","volume":"17","author":"W Wang","year":"2019","unstructured":"Wang W, He Y, Rui J, Xu MQ (2019) miR-410 acts as an oncogene in colorectal cancer cells by targeting dickkopf-related protein 1 via the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett 17(1):807\u2013814. https:\/\/doi.org\/10.3892\/ol.2018.9710","journal-title":"Oncol Lett"},{"key":"11313_CR37","doi-asserted-by":"publisher","first-page":"155433","DOI":"10.1016\/j.cyto.2021.155433","volume":"140","author":"ZH Ma","year":"2021","unstructured":"Ma ZH, Shi PD, Wan BS (2021) MiR-410-3p activates the NF-\u03baB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer. Cytokine 140:155433. https:\/\/doi.org\/10.1016\/j.cyto.2021.155433","journal-title":"Cytokine"},{"key":"11313_CR38","doi-asserted-by":"publisher","first-page":"104861","DOI":"10.1016\/j.yexmp.2023.104861","volume":"131","author":"S Liu","year":"2023","unstructured":"Liu S, Guo XY, Shang QJ, Gao P (2023) The biogenesis, biological functions and modification of circular RNAs. Exp Mol Pathol 131:104861","journal-title":"Exp Mol Pathol"},{"key":"11313_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s12672-024-01602-z","volume":"15","author":"T Latifi-Pakdehi","year":"2024","unstructured":"Latifi-Pakdehi T, Khezrian A, Doosti-Irani A et al (2024) Investigating the biomarker value of circrnas in the diagnosis of colorectal cancer: a systematic review. Discov Onc 15:734. https:\/\/doi.org\/10.1007\/s12672-024-01602-z","journal-title":"Discov Onc"},{"key":"11313_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1517\/14728222.2014.978860","volume":"19","author":"MA Blevins","year":"2015","unstructured":"Blevins MA, Towers CG, Patrick AN, Zhao R, Ford HL (2015) The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opin Ther Targets 19:213\u2013225. https:\/\/doi.org\/10.1517\/14728222.2014.978860","journal-title":"Expert Opin Ther Targets"},{"key":"11313_CR41","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.omtn.2020.10.026","volume":"22","author":"J Xu","year":"2020","unstructured":"Xu J, Zhang Y, Huang Y, Dong X, Xiang Z, Zou J, Wu L, Lu W (2020) circEYA1 functions as a sponge of miR-582-3p to suppress cervical adenocarcinoma tumorigenesis via upregulating CXCL14. Mol Ther Nucleic Acids 22:1176\u20131190. https:\/\/doi.org\/10.1016\/j.omtn.2020.10.026","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"11313_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13046-023-02690-5","volume":"42","author":"F Bersani","year":"2023","unstructured":"Bersani F, Picca F, Morena D, Righi L, Napoli F, Russo M et al (2023) Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity. J Exp Clin Cancer Res 42(1):120. https:\/\/doi.org\/10.1186\/s13046-023-02690-5","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11313-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11313-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11313-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:29:21Z","timestamp":1764656961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11313-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11313"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11313-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate: Prior to enrolment, each participant received an explanation of the study and the opportunity to provide written, informed consent after the research objectives and questions were explained. With Institutional Review Board (IRB) approval number 3\/2023TROP11, the research methodology and sample size calculation were approved by the Faculty of Medicine\u2019s Research Ethics Committee at Menoufia University in Egypt. The study was conducted in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}